Two 64-year-old men were referred to our unit for the devel- opment of a cutaneous manifestation, during the 4th cycle of treatment with tebentafusp for liver metastases from uveal melanomas
Lambertini M., Comito F., Melotti B., Baracca M.F., Dika E. (2023). Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 37(2), e207-e208 [10.1111/jdv.18625].
Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence
Lambertini M.Primo
Writing – Original Draft Preparation
;Comito F.Membro del Collaboration Group
;Baracca M. F.Membro del Collaboration Group
;Dika E.
Ultimo
Writing – Review & Editing
2023
Abstract
Two 64-year-old men were referred to our unit for the devel- opment of a cutaneous manifestation, during the 4th cycle of treatment with tebentafusp for liver metastases from uveal melanomasFile in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
tebentafusp.doc jeadv 2022.pdf
accesso riservato
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per accesso riservato
Dimensione
491.23 kB
Formato
Adobe PDF
|
491.23 kB | Adobe PDF | Visualizza/Apri Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.